Viewing StudyNCT03833661

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 12:44 PM
Last Modification Date: 2024-10-26 @ 1:03 PM
Study NCT ID: NCT03833661
Status: COMPLETED
Last Update Posted: 2023-10-25
First Post: 2019-02-06
Brief Title: M7824 Monotherapy in Locally Advanced or Metastatic Second Line 2L Biliary Tract Cancer Cholangiocarcinoma and Gallbladder Cancer
Sponsor: EMD Serono Research Development Institute Inc
Organization: EMD Serono
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Gallbladder Cancer
Biliary Tract Cancer
Cholangiocarcinoma
Keywords:
Name View
Gallbladder cancer View
M7824 View
Bintrafusp alfa proposed INN View
Transforming growth factor-beta View
First-line Platinum-Based Chemotherapy View
Programmed death-ligand 1 View
Metastatic Biliary Tract Cancer View
Cholangiocarcinoma View